USPTO grants patent to Vistagen’s neuropathic pain treatment
The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...
JD Supra8d
Published Patent Applications as Prior Art: Filing, Not Publication, is Everything
The Federal Circuit recently addressed a deceptively straightforward question: does a published U.S. patent application ...
Trump Return-to-Office Order Faces Big Exemption at Patent Office
The US Patent and Trademark Office told employees Friday the agency will fully comply with President Donald Trump’s return-to ...
JD Supra1d
Federal Circuit Affirms PTAB Jurisdiction Over Expired Patents in IPRs
On January 27, in Apple Inc. v. Gesture Technology Partners, LLC, the Federal Circuit held that the Patent Trial and Appeal Board (PTAB) ...
Forbes1mon
AI Patent Policy Should Promote Economic Growth And Innovation
AI’s Status Under U.S. Patent Law is Uncertain As a new Congressional Research Service Report explains, in 2024 the U.S. Patent and Trademark Office issued separate guidance documents ...
pharmaphorum1y
SCOTUS ruling on PCSK9 could rewrite status quo on patents
In yesterday’s exchange of views, Amgen sought to convince SCOTUS that its core or “genus” patent on blockbuster PCSK9 inhibitor Repatha (evolocumab) was valid and, moreover, should extend ...
Deckard Technologies Granted 3 U.S. Patents for Property Data Collection Systems
Deckard Technologies, a leader in GovTech solutions for property-related challenges, announced that the U.S. Patent and ...